enGene Therapeutics (ENGN) Earnings Date & Reports

enGene Therapeutics Inc is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, to create new ways to address diseases with high clinical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ENGN is expected to report earnings to fall 5.26% to -44 cents per share on December 23

enGene Therapeutics ENGN Stock Earnings Reports

Q4'26

Est.

$-0.45

Q3'26

Missed

by $0.03

Q2'26

Beat

by $0.11

Q1'26

Beat

by $0.10

Q4'25

Missed

by $0.22

The last earnings report on September 08 showed earnings per share of -46 cents, missing the estimate of -43 cents. With 221.59K shares outstanding, the current market capitalization sits at 132.02M.

View a ticker or compare two or three

ENGN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ENGN